Literature DB >> 24797978

Hyperhomocysteinemia, lipid and lipoprotein disturbances in patients with primary hypertension.

Aleksandra Baszczuk1, Katarzyna Musialik2, Jarosław Kopczyński2, Anna Thielemann3, Zygmunt Kopczyński3, Lena Kęsy3, Gabriela Dopierała3.   

Abstract

PURPOSES: The main aim of the study was to answer two questions: what are the concentrations of total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, apo A-I (apolipoprotein A-I), apo B (apolipoprotein B) and Lp(a) (lipoprotein(a)) in serum of patients with primary hypertension and with hyperhomocysteinemia? Is there any correlation between the concentration of homocysteine in blood serum and investigated lipid and lipoprotein parameters in patients with primary hypertension? MATERIAL/
METHODS: We investigated 42 patients with primary hypertension, aged 22-57. The control group consisted of 20 healthy volunteers. The concentration of homocysteine in serum was evaluated using immunochemical method (FPIA - Fluorescence Polarization Immunoassay). The concentration of total cholesterol, LDL-cholesterol, HDL-cholesterol and triglycerides in blood serum were estimated using enzymatic method. Apo A-I, apo B and lipoprotein(a) were assessed using nephelometric method.
RESULTS: The analysis of the results revealed statistically significant lower concentrations of HDL-cholesterol and apo A-I in blood serum of patients with primary hypertension and hyperhomocysteinemia than in the population with hypertension and normohomocysteinemia. Negative correlation between homocysteine and HDL-cholesterol as well as apo A-I has been revealed.
CONCLUSION: Quantitative analysis of the concentration of lipids and lipoproteins in blood serum in patients with primary hypertension and hyperhomocysteinemia may suggest that this type of human population might be more susceptible to atherosclerosis than those with primary hypertension and normal values of homocysteine.
Copyright © 2014 Medical University of Bialystok. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.

Entities:  

Keywords:  Apolipoprotein; Cholesterol; Hyperhomocysteinemia; Hypertension; Triglycerides

Mesh:

Substances:

Year:  2014        PMID: 24797978     DOI: 10.1016/j.advms.2013.08.001

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  7 in total

Review 1.  Emerging risk biomarkers in cardiovascular diseases and disorders.

Authors:  Ravi Kant Upadhyay
Journal:  J Lipids       Date:  2015-04-08

2.  Oxidative stress is associated with not only coronary artery disease on statin therapy but also diabetes mellitus and hypertension.

Authors:  Ibrahim Halil Altiparmak; Muslihittin Emre Erkus; Ozgur Gunebakmaz
Journal:  Indian Heart J       Date:  2016-01-11

3.  Prevalence and correlative factors of hyperhomocysteinemia in elderly patients with femoral neck fracture: A cross-sectional study.

Authors:  Kun Tao; Ming Li; Jing Ling; Yiji Tu
Journal:  J Clin Lab Anal       Date:  2022-06-17       Impact factor: 3.124

4.  Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing Mendelian randomization.

Authors:  Liwan Fu; Ya-Nan Li; Dongmei Luo; Shufang Deng; Baihui Wu; Yue-Qing Hu
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-25       Impact factor: 3.738

5.  Association of homocysteine with carotid atherosclerosis in hypertension.

Authors:  Ai Chen; Weibin Wu; Jin Gong; Ying Han; Guoyan Xu; Liangdi Xie
Journal:  J Hum Hypertens       Date:  2022-03-11       Impact factor: 2.877

6.  Corrective effects of hepatotoxicity by hepatic Dyrk1a gene delivery in mice with intermediate hyperhomocysteinemia.

Authors:  Alizée Latour; Sacha Salameh; Christel Carbonne; Fabrice Daubigney; Jean-Louis Paul; Micheline Kergoat; Valérie Autier; Jean-Maurice Delabar; Bart De Geest; Nathalie Janel
Journal:  Mol Genet Metab Rep       Date:  2015-01-13

7.  Association of LIPC -250G/A and -514C/T polymorphisms and hypertension: a systematic review and meta-analysis.

Authors:  Xingsheng Zhao; Yu Ren; Hui Li; Yun Wu
Journal:  Lipids Health Dis       Date:  2018-10-15       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.